Preprint Servers Explained: bioRxiv, medRxiv, arXiv, and Real Tradeoffs
Preprint servers are not interchangeable. The right choice depends on field norms, public-health risk, moderation, journal policy, and whether early visibility helps or harms your workflow.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: Preprints are now normal in some fields, optional in others, and still strategically misunderstood almost everywhere.
Authors often ask one blunt question: "Should I post a preprint?" That is too crude. The better questions are:
- which server fits my field
- what gets screened before posting
- what can no longer be quietly reversed after public release
- how does this affect journal submission, visibility, and timing
The right answer depends on more than speed.
Short answer
Use this first:
Server | Best for | Key practical difference |
|---|---|---|
bioRxiv | Life sciences | Research manuscripts with new data, plus bio-specific screening |
medRxiv | Clinical and health research | Stricter safeguards because public-health misuse is a real risk |
arXiv | Physics, math, CS, quantitative fields | Deep field norm, huge scale, and fast research visibility |
If your work is biomedical but not clinically actionable, bioRxiv is often the default. If the manuscript could influence clinical practice or health behavior, medRxiv is the higher-scrutiny route. If your field already lives on arXiv, not posting can be the unusual choice.
What a preprint actually is
ASAPbio gives the cleanest baseline definition: a preprint is a scientific manuscript posted publicly before journal acceptance. It has data and methods, but it has not yet been accepted by a journal.
Two practical details from the ASAPbio FAQ matter more than most authors realize:
- many servers post rapidly, often within a day or so after screening
- most servers support versioning, but earlier versions are commonly retained and are not typically removable
That means posting a preprint is not just "sharing early." It is creating a durable public record earlier than journal publication would.
The first question: why are you posting?
Preprints solve different problems for different researchers.
ASAPbio highlights recurring benefits:
- faster dissemination
- visible evidence of productivity
- earlier feedback
- earlier collaboration opportunities
- priority timestamping
- free access for readers
Those are real advantages. But they help most when early visibility is actually useful to your field and career stage. If you are posting mostly because everyone says preprints are modern, that is not yet a strategy.
Major 2025 Change: openRxiv
In March 2025, bioRxiv and medRxiv moved from Cold Spring Harbor Laboratory to a new independent nonprofit called openRxiv, backed by a $16 million grant from the Chan Zuckerberg Initiative. This is the most significant governance change since bioRxiv launched in 2013.
What it means for authors: nothing changes operationally (same submission systems, same URLs, same screening). What it means structurally: the servers are now independently governed rather than dependent on one laboratory's infrastructure and budget. The combined operation runs on about $3 million per year.
Scale context: bioRxiv has posted ~268,000 preprints from ~970,000 authors and adds ~4,000 new preprints monthly. medRxiv has posted ~64,000 preprints from ~380,000 authors with ~1,000 new submissions monthly. Combined, they've published more preprints than any biology server other than arXiv.
Cross-posting restriction: You cannot post the same manuscript to both bioRxiv and medRxiv. Doing so will result in article withdrawal. Choose one based on whether the content is clinical/health (medRxiv) or basic biology (bioRxiv).
bioRxiv: best for life-science research with data
bioRxiv is the right starting point for many non-clinical biology manuscripts, but its screening is more structured than some authors assume.
bioRxiv's published description of its screening procedures says:
- submissions must be within scope and an appropriate article type
- a research manuscript is acceptable, but a narrative review, commentary, opinion piece, or step-by-step protocol is not
- submissions undergo automated checks for potential plagiarism and prior online appearance
- volunteer bioRxiv Affiliates assess whether the submission is biological research and whether there is potential for public harm
That means bioRxiv is not a dump-it-and-go repository. It is a moderated research server with a clear preference for data-bearing articles.
Choose bioRxiv if:
- your paper is squarely in life sciences
- it contains new data
- you want early visibility without the extra clinical-risk burden that comes with medRxiv
medRxiv: best for clinical and health research when you need public visibility with stronger safeguards
medRxiv exists because medical preprints create a harder problem than most other preprints. Incorrect or overstated claims can influence care, public behavior, or news coverage before peer review.
The platform makes that risk explicit. Its public site warns that medRxiv and bioRxiv health-related preprints are preliminary reports that have not been peer reviewed and should not guide clinical practice or health-related behavior or be reported in the news as established information.
That warning is not window dressing. It tells you what medRxiv is built for: rapid visibility with heavier caution.
ASAPbio also notes that medical preprint servers generally perform more stringent screening than bioRxiv because of the greater public-harm risk.
Choose medRxiv if:
- the paper is clinical, medical, epidemiologic, or public-health facing
- the potential downstream misuse of a weak claim is real
- you want the benefits of preprinting but need the right risk posture
Do not choose medRxiv because it sounds more prestigious than bioRxiv. Choose it because the content domain and public stakes fit.
arXiv: best when your field already treats preprints as part of the publication system
arXiv is not just another server. It is the long-standing preprint backbone for fields like physics, mathematics, computer science, and several adjacent quantitative areas.
Its 2022 annual report shows the scale clearly:
- 185,692 new submissions in 2022
- 5 million+ monthly active users
- 2.6 billion total downloads
- 204 moderators
- no paywalls to read or submit
That is a different kind of ecosystem from a newer field-specific server. In many arXiv-heavy disciplines, the preprint is part of ordinary scholarly communication, not a side experiment.
Community discussions on Academia Stack Exchange reflect that norm strongly. Researchers in arXiv-native fields often describe posting at or near journal submission as standard practice rather than a risky edge case.
Choose arXiv if:
- your field already expects it
- priority and visibility move fast
- readers genuinely monitor arXiv as part of the literature workflow
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Are preprints compatible with journals?
In many cases, yes.
ASAPbio says that in many fields, the majority of journals allow submission and citation of preprints, while also warning authors to check the target journal's current policy before posting.
Nature Communications is especially clear: it says preprint archives do not compromise novelty. It also encourages preprint deposition and offers the integrated In Review service with Research Square, which posts the originally submitted version with a permanent DOI and can display that the manuscript is under review while the journal considers it.
This matters because some authors still behave as if preprinting automatically weakens their chances at selective journals. In many modern cases, that assumption is outdated.
Still, compatibility is not universal across all venues or all review models. Double-blind settings, conference rules, and discipline-specific expectations can complicate the calculation.
1. Speed versus reversibility
Preprints are fast. That is the point.
But speed comes with reduced reversibility. ASAPbio notes that prior versions are usually retained. medRxiv preprints are displayed under a warning banner. Some servers state or imply long-term display. This means a rushed preprint can remain attached to your name and DOI trail even after the paper evolves.
2. Priority versus scrutiny
Posting early can establish precedence and invite useful feedback. It can also expose a weak argument before you are ready to defend it.
In fast-moving fields, that tradeoff is often worth it. In fragile or still-underpowered projects, it may not be.
3. Openness versus double-blind tension
ASAPbio explicitly notes that preprints can make double-blind review harder to preserve. Community discussions on Academia Stack Exchange echo the same concern, especially for conference workflows where title-searching can reveal authorship.
For many journals, this does not block submission. But if anonymity is strategically important in your venue, you should think about timing before posting.
4. Visibility versus public-health risk
This is where medRxiv differs most clearly from the others. Clinical claims can travel faster than caveats. If your work could influence behavior, the wording and uncertainty framing matter much more at preprint stage than authors sometimes assume.
Which server should you choose?
Use this practical table:
Your situation | Best fit |
|---|---|
Molecular, cell, or systems biology paper with new data | bioRxiv |
Clinical, public-health, or medically actionable paper | medRxiv |
Physics, mathematics, machine learning, or theoretical work in arXiv-native fields | arXiv |
Multidisciplinary journal submission with integrated preprint posting | Journal-linked option such as In Review, if it fits your workflow |
When not to post yet
You probably should not rush a preprint if:
- the core claim is still unstable
- the manuscript could create harmful clinical overinterpretation
- you have not checked the target venue's policy
- the draft would benefit from one serious external critique before public release
This is where readiness matters. A preprint is public strategy, not just file storage.
If you are unsure whether the manuscript is coherent enough for that step, use manuscript readiness check first. Then review open access mandates 2026 and how to get published in a top journal to decide how public posting fits the broader submission plan.
Verdict
bioRxiv, medRxiv, and arXiv serve overlapping but not identical purposes.
bioRxiv is the right default for many life-science data papers. medRxiv is the right place when medical or public-health stakes require stronger caution. arXiv is the dominant visibility engine in fields that already treat preprints as part of normal scholarly communication.
The decision is not "preprint or no preprint." It is whether early public visibility helps your paper more than it constrains it.
Frequently asked questions
The main differences are field focus and screening intensity. bioRxiv is built for life-science research articles with new data, medRxiv is for health and clinical research with stricter public-harm safeguards, and arXiv is the long-established multidisciplinary server most dominant in physics, mathematics, computer science, and related fields.
In many fields, yes. ASAPbio notes that most journals allow submission and citation of preprints, but authors should still check the current policy of the specific target journal before posting.
Usually not in the simple sense authors imagine. Most servers support versioning, but prior versions are often retained to preserve the scholarly record, and some platforms display manuscripts in perpetuity.
It carries higher public-communication stakes because medical claims can influence care and behavior. That is why medRxiv applies stronger screening and prominently warns that posted work is not peer reviewed and should not guide clinical practice.
Often no, but you must check the journal. Nature Communications explicitly says preprint archives do not compromise novelty, and many researchers in preprint-heavy fields treat preprint posting as a normal part of the publication workflow.
Sources
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.